FATE vs WDAY · rev $3.4M vs P/E 135, rev $5.19B
Fate Therapeutics Inc (FATE) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
FATE currently screens at market cap $331.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the FATE and WDAY stock pages for the full models.
Not investment advice.